Lysophosphatidylinositol Signalling and Metabolic Diseases

Author： Arifin Syamsul A.   Falasca Marco  

Publisher： MDPI

E-ISSN： 2218-1989|6|1|6-6

ISSN： 2218-1989

Source： Metabolites, Vol.6, Iss.1, 2016-01, pp. : 6-6

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic Diseases

By Jung Tae Woo   Choi Kyung Mook  

International Journal of Molecular Sciences, Vol. 17, Iss. 2, 2016-02 ,pp. : 192-192

MDPI

Access to resources Recommend Favorite

Impact of DHA on Metabolic Diseases from Womb to Tomb

By Arnoldussen Ilse A. C.   Kiliaan Amanda J.  

Marine Drugs, Vol. 12, Iss. 12, 2014-12 ,pp. : 6190-6212

MDPI

Access to resources Recommend Favorite

Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?

By Pap Attila   Cuaranta-Monroy Ixchelt   Peloquin Matthew   Nagy Laszlo  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-07 ,pp. : 1236-1236

MDPI

Access to resources Recommend Favorite

The Spleen: A Hub Connecting Nervous and Immune Systems in Cardiovascular and Metabolic Diseases

By Lori Andrea   Perrotta Marialuisa   Lembo Giuseppe   Carnevale Daniela  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1216-1216

MDPI

Access to resources Recommend Favorite

Altered Circadian Timing System-Mediated Non-Dipping Pattern of Blood Pressure and Associated Cardiovascular Disorders in Metabolic and Kidney Diseases

By Rahman Asadur   Hasan Arif Ul   Nishiyama Akira   Kobori Hiroyuki  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 400-400

MDPI

Access to resources Recommend Favorite